Previous close | 1.2700 |
Open | 1.2700 |
Bid | 0.0000 |
Ask | 3.7000 |
Strike | 3.00 |
Expiry date | 2024-08-16 |
Day's range | 1.2500 - 1.2700 |
Contract range | N/A |
Volume | |
Open interest | 3.19k |
Significant Revenue Growth Amidst Strategic Shifts and Clinical Developments
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript May 9, 2024 Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24. AMLX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
Amylyx Pharmaceuticals (AMLX) delivered earnings and revenue surprises of -291.67% and 21.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?